Abstract: Methods and apparatus for the treatment of a body cavity or lumen are described where a heated fluid and/or gas may be introduced through a catheter and into treatment area within the body contained between one or more inflatable/expandable members. The catheter may also have optional pressure sensing elements which may allow for control of the pressure within the treatment zone and also prevent the pressure from exceeding a pressure of the inflatable/expandable members to thereby contain the treatment area between these inflatable/expandable members. Optionally, a chilled or room temperature fluid such as water may then be used to rapidly terminate the treatment session.

Abstract: A stent delivery catheter for positioning a stent across a lesion of a blood vessel is disclosed. The catheter includes an inflation balloon coupled to a distal region of the elongate shaft of the catheter and a stent loaded on the inflation balloon. The catheter may also include an occlusion balloon having a proximal waist secured to the elongate shaft and a distal waist secured to the elongate shaft. The occlusion balloon includes a first folded-over portion extending distal of the distal waist to a distalmost extent of the occlusion balloon and a second folded-over portion extending proximal of the proximal waist to a proximalmost extent of the occlusion balloon. The catheter further includes a fluid discharge port located distal of the occlusion balloon for discharging a lubricious fluid exterior of the elongate shaft toward the stent to facilitate advancing the stent across an occlusion.

Abstract: A medical device tunneling system, and a method of using the same, to subcutaneously route trocars, also commonly referred to as tunnelers, or introducers, having a cannula, stylet, and a guidewire stylet, inside a patient during a surgical procedure, such as a ventriculoperitoneal hydrocephalus shunt implantation, from a proximal entry point to a distal end point, in order to subcutaneously route and implant a medical device, such as shunt tubing, in a patient.

Abstract: A centering tool and a combined centering-indicator tool for finding the magnetic center and indicating the setting of an implantable adjustable valve. The centering and combined centering-indicator tools include a magnetic capsule movable within a cavity to a target located on the tool when the magnetic capsule is centered over magnet of an adjustable valve.

Abstract: A device for delivering an active agent to a tissue (100), comprising; a housing (10) including a reservoir (20) for containing said active agent; a delivery tip (35) being in fluid communication with said reservoir; and, a delivery mechanism (40) capable of delivering a predetermined amount of said active agent and releasing the same upon contact between said delivery tip and said tissue.

Abstract: A method for operating a system for repetitive local puncturing of skin is provided. The system having a handheld applicator device provided with a puncturing device configured to repetitively puncture skin and a control device connected to the handheld applicator device and configured to control operation of the applicator device. The method includes receiving a user selection for a body skin part to which repetitive local puncturing is to be applied in the control device, responsively providing a set of operation parameters in the control device, the set of operation parameters defining a mode of operation of the applicator device for repetitive local puncturing, and operating the applicator device according to the mode of operation defined by the set of operation parameters with the operating of the applicator device being controlled by the control device. Also, a system for repetitive local puncturing a skin is provided.

Abstract: An introducer assembly for introducing a catheter into a patient, includes a sheath having a distal end and a proximal end with a hollow lumen extending between the distal end and proximal end. The assembly also includes a coupler having a distal end operatively coupled to the proximal end of the sheath, the coupler having an internal passage in fluid communication with the hollow lumen. The assembly further includes a connector having a distal end operatively coupled to the coupler proximate the distal end of the coupler.

Abstract: In a blood-flow-path switching device and a blood-bag system, a tube-shaped body (68) includes a body tube (69) extending in an axial direction and a branching tube (71) extending in a direction branching from the axial direction, and a blocking part (74) is provided in a hollow section (69c) of the body tube (69). A communicating part (70) movable in the axial direction is provided in the hollow section (69c). By moving the communicating part (70) in a pushing direction and creating an opening by penetrating the blocking part (74), a communication of a first port (86) and a third port (90) is blocked, and at the same time, the first port (86) and a second port (88) are communicated with each other.

Abstract: An accessory kit for use with a wearable medical device, such as a wearable defibrillator, that includes a control unit and a first plurality of electrodes electrically coupled to the control unit. The first plurality of electrodes includes a first plurality of ECG sensing electrodes and a first plurality of therapy electrodes configured to provide a defibrillating shock to a body of a patient. The accessory kit includes a waterproof enclosure configured to receive the control unit and protect the control unit during operation in a wet environment and a second plurality of electrodes that are electrically coupled to a connector configured to removably and electrically couple to the control unit. The second plurality of electrodes includes a second plurality of ECG sensing electrodes and a second plurality of therapy electrodes configured to provide a defibrillating shock to the body of the patient.

Abstract: A modular multi-channel inline connector system that connects an implanted electrode within a body of an organism, such as the human body, with a device located external to or implanted within the body. The modular multi-channel inline system comprises of a first lead operatively connected to the implanted electrode and to a first connector portion. A second lead is operatively connected to a second connector portion and operatively connected to the device. One of the first and second connector portions comprises a male connector and the other of the first and second connector portions comprises a female connector. The first and second connector portions are arranged to connect with each other and to be operatively located embedded within the body.

Abstract: An implantable peripheral neurostimulation lead for head pain is adapted for implantation in the head for the therapeutic purpose of treating chronic head and/or face pain. The lead may include an extended lead body, a plurality of internal electrically conducting metal wires running along at least a portion of its length and individually connecting to a proximal surface contact and a distal surface electrode; a distal extended metal surface electrode array, subdivided into a plurality of sub-arrays; and a proximal in-line connector, which may include a proximal surface contact array adapted to couple with a separate implantable pulse generator. The lead may be operable to provide medically acceptable therapeutic neurostimulation to multiple regions of the head, including the frontal, parietal, and occipital regions of the head simultaneously.

Abstract: A stimulation lead includes a lead body having a longitudinal length, a distal portion, and a proximal portion; terminals disposed along the proximal portion of the lead body; an electrode carrier coupled to, or disposed along, the distal portion of the lead body; segmented electrodes disposed along the electrode carrier; and conductors extending along the lead body and coupling the segmented electrodes to the terminals. The electrode carrier includes a lattice region defining segmented electrode receiving openings. Each of the segmented electrodes extends around no more than 75% of a circumference of the lead and is disposed in a different one of the segmented electrode receiving openings of the electrode carrier.

Abstract: A tip member for inserting into the cochlea, a device comprising: an elongate member including at least one electrode mounted thereon; and a tip member extending distally from a distal end of the elongate member, the tip member comprising a tapered portion tapering distally and a blunt end portion at a distal end of the tapered portion, wherein the tip member is resiliently flexible, and a method for making such a device.

Abstract: A structure of an artificial electronic retina is disclosed, which includes an array of a plurality of photoelectric units, and each photoelectric unit includes one electronic photosensitive element, one microelectrode, one electronic circuit, and sidewalls surrounding the photoelectric unit, wherein the microelectrode is disposed on and electrically connected to the electronic photosensitive element, and the electronic circuit is disposed on the electronic photosensitive element adjacent to the sidewalls near the circumference of the electronic photosensitive element. A layer of a light-permeable conductive material is disposed on the electronic photosensitive element between the microelectrode and the electronic circuit, wherein the layer of the light-permeable conductive material is electrically connected to both the electronic photosensitive element and the microelectrode.

Abstract: Devices, systems and methods are provided for stimulating a target tissue, particularly a dorsal root ganglion. The devices and systems have one or more electrodes, wherein the electrodes are positionable in disperse locations within the specific target area. In some embodiments, the position of at least some of the electrodes is adjustable and optionally independently positionable. Some or all of the electrodes may be used to stimulate the desired tissue, such as to stimulate a specific portion of the target area. Or, the one or more electrodes that fall near the target tissue may be used to stimulate the tissue while the other electrodes are not used. When stimulating the dorsal root ganglion, sensory pain signals are blocked providing relief to the patient.

Abstract: An implantable biomedical conductor assembly is configured for at least partial insertion in a living body. The implantable conductor assembly includes an inner tubular structure and an outer tubular structure generally surrounding the inner tubular structures such that a gap of less than about 0.030 inches exists there between. A dynamic coil is located in the gap. The dynamic coil includes a plurality of insulated conductors that are coiled generally at or below a yield point. The insulated conductors are permitted to expand within the gap to engage an inner surface of the outer tubular structure in an expanded coiled configuration. At least one mechanical restraint at each of a distal end and a proximal end retains the dynamic coil in the tubular structures. Free ends of the insulated conductors extend beyond the proximal and distal ends to facilitate attachment to electrodes and connectors.

Abstract: An implantable medical device comprises one or more electrical stimulation generators, and a housing that contains the one or more electrical stimulation generators. The implantable medical device includes a first connector block that electrically connects the first medical lead to at least one of the one or more electrical stimulation generators, and a second connector block that electrically connects the second medical lead to at least one of the one or more electrical stimulation generators.

Abstract: One embodiment of an electrode lead comprises a lead body, at least one electrode at a distal end of the lead body, an actuatable member and at least one anchor wire. The actuatable member is positioned within a lumen of the lead body. The at least one anchor wire has a proximal end that is attached to the actuatable member. Movement of the actuatable member relative to the lead body moves the at least one anchor wire through at least one opening in the lead body.

Abstract: Anchoring devices and methods for affixing an implanted lead of a neurostimulation system at a target location in a patient are provided herein. Such anchoring devices includes a helical body having a plurality of tines extending laterally outward from the lead when deployed that engage tissue to inhibit axial movement of the implanted lead. The plurality of tines are biased towards the laterally extended deployed configuration and fold inward towards the lead to a delivery configuration to facilitate delivery of the lead through a sheath. The tines may be angled in a proximal direction or in both proximal and distal directions and may include various features to assist in visualization and delivery of the lead. The anchor may be formed according to various methods, including laser cutting of a tubular section along with heat or reflow to set the material with the anchor in the deployed configuration and injection molding.

Abstract: An extendable medical lead comprises a lead body and a sheath defining a cavity that encloses a length of the lead body. The length of the lead body enclosed within the sheath may be coiled or otherwise gathered such that when extended, the length of the enclosed section of the lead body is greater than the length of the sheath. The sheath may include a seal to help prevent contaminant entry into the cavity in order to help reduce tissue in growth around the length of the lead body disposed within the sheath. A portion of the length of the lead body enclosed within the sheath exits the cavity through an aperture defined by the seal when a tensile force is applied to the lead body.

Abstract: An epicardial screw lead for stimulation/defibrillation implantable by a guide-catheter inserted into the pericardial space is described. The lead is a monodiameter lead with a helical anchoring screw extending axially of the lead body. The guide-catheter (24) has a pre-shaped tube having, in the absence of stress, a first bend (26) for supporting the lead body on the outer wall of the pericardial space (38), and a second bend (28) for orienting the end of the guide-catheter tube in the direction of the outer wall of the myocardium (34) and keeping the axis of the anchoring screw (14) in that same direction during a combined movement of screwing and insertion of the lead head.

Abstract: Disclosed is a method for the diagnosis of conductor anomalies, such as an insulation failure resulting in a short circuit, in an implantable medical device, such as an implantable cardioverter defibrillator (ICD). Upon determining if a specific defibrillation pathway is shorted, the method excludes the one electrode from the defibrillation circuit, delivering defibrillation current only between functioning defibrillation electrodes. Protection can be provided against a short in the right-ventricular coil-CAN defibrillation pathway of a pectoral, transvenous ICD with a dual-coil defibrillation lead. If a short caused by an in-pocket abrasion is present, the CAN is excluded from the defibrillation circuit, delivering defibrillation current only between the right-ventricular and superior vena cava defibrillation coils. Determination that the defibrillation pathway is shorted may be made by conventional low current measurements or delivery of high current extremely short test pulses.

Abstract: Improved pharmacokinetic profiles for the iontophoretic delivery of sumatriptan are described.

Abstract: A renal denervation feedback method is described that performs a baseline measurement of renal nerve plexus electrical activity at a renal vessel; denervates at least some tissue proximate the renal vessel after performing the baseline measurement; performs a post-denervation measurement of renal nerve plexus electrical activity at the renal vessel, after the denervating; and assesses denervation of the renal vessel based on a comparison of the baseline measurement and the post-denervation measurement of renal nerve plexus electrical activity at the renal vessel.

Abstract: An implantable system for stimulating the release of satiety hormone in a subject comprises a stimulus device which is implantable in the subject and adapted to apply an electrical stimulus to a tissue of a gastrointestinal system of said subject, and a detection device which is implantable in the subject and adapted to continuously monitoring at least one of a mechanical characteristic and an electrical characteristic of the subject to detect an ingestion of food by said subject, wherein the detection device cooperates with the stimulus device such that the stimulus device applies said electrical stimulus in response to a detected ingestion of food.

Abstract: Devices, systems and methods for treating medical disorders, such as migraine or other primary headaches, or fibromyalgia, by noninvasive electrical stimulation of a vagus nerve, used in conjunction with the measurement of evoked potentials (EPs). The system comprises a stimulator that is applied to the surface of the patient's neck to apply electrical impulses sufficient to stimulate a cervical vagus nerve, scalp electrodes that are used to measure EPs that are evoked by that stimulation, feedback or biofeedback circuits to vary the stimulation based upon EP characteristics, and other sensory stimulation modalities that produce EPs. The system is preferably used to optimize the placement of the stimulator, to test whether a patient is a suitable candidate for treatment using vagus nerve stimulation, and to select the stimulation parameters that optimized acute or chronic treatment, e.g., by correcting an EP habituation deficit.

Abstract: Polymer materials are useful as electrode array bodies for neural stimulation. They are particularly useful for retinal stimulation to create artificial vision, cochlear stimulation to create artificial hearing, and cortical stimulation, and many related purposes. The pressure applied against the retina, or other neural tissue, by an electrode array is critical. Too little pressure causes increased electrical resistance, along with electric field dispersion. Too much pressure may block blood flow. Common flexible circuit fabrication techniques generally require that a flexible circuit electrode array be made flat. Since neural tissue is almost never flat, a flat array will necessarily apply uneven pressure. Further, the edges of a flexible circuit polymer array may be sharp and cut the delicate neural tissue. It is advantageous that the array edges not contact tissue.

Abstract: Devices, systems and methods are described by which the blood pressure, nervous system activity, and neurohormonal activity may be selectively and controllably reduced by activating baroreceptors. A baroreceptor activation device is positioned near a baroreceptor, preferably a baroreceptor located in the carotid sinus. A control system may be used to modulate the baroreceptor activation device. The control system may utilize an algorithm defining a stimulus regimen which promotes long term efficacy and reduces power requirements/consumption. The baroreceptor activation device may utilize electrodes to activate the baroreceptors. The electrodes may be adapted for connection to the carotid arteries at or near the carotid sinus, and may be designed to minimize extraneous tissue stimulation.

Abstract: The present disclosure involves a method of generating different stimulation waveforms as a part of sacral nerve stimulation therapy. A first stimulation waveform having a first stimulation waveform characteristic is generated. The first stimulation waveform is delivered to a first body part of a patient at least in part via a first channel. A second stimulation waveform having a second stimulation waveform characteristic is generated. The second stimulation waveform characteristic is different from the first stimulation waveform characteristic. The second stimulation waveform is delivered to a second body part of the patient at least in part via a second channel that is separate and independent from the first channel. The first body part and second body part correspond to different organs or different types of nerves.

Abstract: Systems and methods for treating a neurological disorder comprising determining a first set of neural stimulation parameters capable of treating a first subset of symptoms, determining a second set of neural stimulation parameters capable of treating a second subset of symptoms, and applying a neural stimulation therapy based upon the first set of neural stimulation parameters and the second set of neural stimulation parameters to the patient. The first set of neural stimulation parameters can include electrical stimulation at a first frequency, and the second set of neural stimulation parameters can include electrical stimulation at a second frequency. In other embodiments, a treatment method comprises applying a first neural stimulation therapy to the patient in a continuous or generally continuous manner during a first time interval, and applying a second neural stimulation therapy to the patient in a noncontinuous or interrupted manner following the first time interval.

Abstract: A method and apparatus for treatment of hypertension and heart failure by increasing vagal tone and secretion of endogenous atrial hormones by excitory pacing of the heart atria. Atrial pacing is done during the ventricular refractory period resulting in atrial contraction against closed AV valves, and atrial contraction rate that is higher than the ventricular contraction rate. Pacing results in the increased atrial wall stress. An implantable device is used to monitor ECG and pace the atria in a nonphysiologic manner.

Abstract: A system can include a sensor array comprising a plurality of sensors configured to measure electrical activity across a body surface of a patient and generate electrical data characterizing the measured electrical activity. The plurality of sensors are arranged at predetermined locations for placement over the patient's body to define at least one predetermined zone of the patient's body that maps deterministically to at least one predetermined region of interest of at least one internal anatomical structure of the patient. A control system is configured to analyze the electrical data for the at least one predetermined zone to provide a surrogate estimate of electrical activity at the at least one predetermined region of interest. The control system also is configured to control delivery of a therapy to the patient based on the surrogate estimate of electrical activity at the at least one predetermined region of interest.

Abstract: Approaches for selecting an electrode combination of multi-electrode pacing devices are described. Electrode combination parameters that support cardiac function consistent with a prescribed therapy are evaluated for each of a plurality of electrode combinations. Electrode combination parameters that do not support cardiac function are evaluated for each of the plurality of electrode combinations. An order is determined for the electrode combinations based on the parameter evaluations. An electrode combination is selected based on the order, and therapy is delivered using the selected electrode combination.

Abstract: A leadless cardiac pacemaker (LCP) configured to sense and pace a patient's heart includes a sensor configured to sense a parameter related to cardiac contractility of the patient's heart and a power management unit that is operatively coupled to the sensor. The power management unit is configured to place the sensor in a higher power sense mode during times when sensing the parameter related to cardiac contractility is desired and to place the sensor in a lower power mode during times when sensing the parameter related to cardiac contractility is not desired.

Abstract: An implantable electrostimulation assembly, including an electrostimulation device and an electrode lead that is connected to the electrostimulation device when in use, wherein the electrode lead has an optically readable electrode identification and a cable adapter is provided for the temporary insertion between the electrostimulation device and the electrode lead, the adapter comprising an optical pick up device for reading the electrode identification and an electrode identification transmission stage for transmitting the same to the electrostimulation device and/or to an assembly-external receiver.

Abstract: A base station for passively recharging a battery in an implant without patient involvement is disclosed. The base station can be hand held or may comprise equipment configured to be placed at a fixed location, such as under a bed, on or next to a wall, etc. The base station can generate electric and magnetic fields (E-field and B-field) that couple with an antenna and a receiving coil within the implant to generate a charging current for charging the implant's battery. No handling or manipulation on part of the patient is necessary; the implant battery is passively charged whenever the patient is within range of either the magnetic or electric charging fields generated by base station. Charging using the B-field occurs when the IPG is at a relatively short distance from the base station, while charging using the E-field occurs at longer distances.

Abstract: Techniques are provided for use with implantable medical devices or trial medical devices for wirelessly connecting the devices to external instruments such as tablet computers or smartphones. In an example where the medical device is an implantable neurostimulator, the neurostimulator passively detects wireless wake-up signals generated by the external instrument, i.e. the neurostimulator “sniffs” for advertisement signals generated by the external instrument. In response to passive detection of a wake-up signal, the implantable neurostimulator determines if a response is warranted and, if so, the neurostimulator activates its wireless transmission components to transmit an acknowledgement signal to the external instrument so as to complete a wake-up and handshake protocol.

Abstract: A system and method for estimating the current delivered to a patient during voltage-regulated electrical stimulation therapy by an implantable medical device includes calculating a total charge delivered and a peak current delivered and the time at which the peak current was delivered using a proxy for the current delivered to the patient and a component such as a current controlled oscillator, the output of which is proportional to the current proxy together with memory for storing values relating to the output proportional to the current proxy. The stored values also may be used to construct a waveform approximating the current delivered to the patient during a therapy of voltage-regulated stimulation. The system and method may be implemented in an active implantable medical device such as an implantable neurostimulator.

Abstract: A distributed leadless implantable system and method are provided that comprise a leadless implantable medical device (LIMD). The LIMD comprises a housing having a proximal end configured to engage local tissue of interest in a local chamber, cardiac sensing circuitry to sense cardiac signals; and a controller configured to analyze the cardiac signals and, based thereon, to produce a near field (NF) event marker indicative of a local event of interest (EOI) occurring in the local chamber. The system and method further comprise a subcutaneous implantable medical device (SIMD). The SIMD comprises cardiac sensing circuitry to sense cardiac signals, a controller configured to identify a candidate EOI from the cardiac signals, and pulse sensing circuitry to detect the NF event marker from the LIMD. The SIMD controller is configured to declare the candidate EOI as a valid EOI or an invalid EOI based on the NF event marker.

Abstract: A neurostimulation patch is affixed to a patient's skin (e.g., via a medical skin adhesive) and provides stimulation energy for an implanted lead. The patch may be used for SCS trials or other applications where is it desirable to avoid implanting a stimulation device within a patient. Circuitry in the patch generates stimulation signals and couples these signals to the implanted lead. The signals may be coupled to the lead via a direct physical connection or via a wireless connection. In some embodiments, the neurostimulation patch is configured in a manner that enables the patch to be placed immediately above the puncture site where an associated percutaneous lead passes through a patient's skin, thereby protecting the puncture site and facilitating secure routing of the lead.

Abstract: A hermetically sealed filtered feedthrough assembly for an AIMD includes an electrically conductive ferrule with an electrically conductive extension at least partially extending into the ferrule opening. An electrically non-conductive insulator hermetically seals the ferrule opening. An electrically conductive pathway is hermetically sealed and disposed through the insulator between a body fluid and device side. A filter capacitor is located on the device side. A first low impedance electrical coupling is between a first metallization of the filter capacitor and the pathway. A ground conductor is disposed through the filter capacitor in non-conductive relation with the at least one active and ground electrode plates, where the ground conductor is electrically coupled to the extension of the ferrule. An oxide-resistant metal addition is disposed on the device side and electrically couples the ground conductor to the second metallization of the filter capacitor.

Abstract: A system and method of detecting a loss of electrical contact between a pair of electrodes that are electrically coupled to skin of a subject. The method includes monitoring parameters of a transthoracic impedance between the pair of electrodes in at least one of a low frequency regime and a high frequency regime, detecting an occurrence of chest compressions based on a signal indicative of chest compressions, establishing baseline levels of the parameters in at least one of the low and high frequency regimes, detecting whether changes in at least one parameter exceeds the baseline level by a threshold, determining that at least one electrode of the pair of electrodes is losing electrical contact with the skin responsive to the at least one parameter exceeding the baseline level by the threshold, and issuing an alert in response to a determination that the at least one electrode is losing electrical contact.

Abstract: Embodiments of the invention include methods of treating neurological injury and conditions, in particular, traumatic brain injury and physiological responses arising from injury or conditions. These treatment methods can include the steps of generating a pulsed electromagnetic field from a pulsed electromagnetic field source and applying the pulsed electromagnetic field 1 in proximity to a target region affected by the neurological injury or condition to reduce a physiological response to the neurological injury or condition.

Abstract: A multi-resolution detector includes a high-resolution pixelated electrode and a low-resolution pixelated electrode. The high-resolution pixelated electrode includes a plurality of sub-arrays of first pixels. Each respective first pixel at each relative position in each sub-array is electrically connected in parallel with one another. The low-resolution pixelated electrode includes a plurality of second pixels. A control system receives as inputs an output from each pixelated detector. The control system uses the inputs to determine a physical position and a transverse intensity distribution of an incident charged particle pencil beam at the resolution of the high-resolution pixelated electrode.

Abstract: A system and method for ultrasound treatment of skin laxity are provided. Systems and methods can include ultrasound imaging of the region of interest for localization of the treatment area, delivering ultrasound energy at a depth and pattern to achieve the desired therapeutic effects, and/or monitoring the treatment area to assess the results and/or provide feedback. In an embodiment, a treatment system and method can be configured for producing arrays of sub-millimeter and larger zones of thermal ablation to treat the epidermal, superficial dermal, mid-dermal and deep dermal components of tissue.

Abstract: Methods for treating skin and subcutaneous tissue with energy such as ultrasound energy are disclosed. In various embodiments, ultrasound energy is applied at a region of interest to affect tissue by cutting, ablating, micro-ablating, coagulating, or otherwise affecting the subcutaneous tissue to conduct numerous procedures that are traditionally done invasively in a non-invasive manner. Methods of lifting sagging tissue on a face and/or neck are described.

Abstract: A system and method are disclosed for stimulating activation of heat shock proteins and facilitating protein repair in cells and tissues in order to take advantage of the remediative and restorative nature of the increased heat shock protein activation or production and the facilitation of protein repair, while not damaging the cells and tissues. This is accomplished by treating a specified target area with an ultrasound or electromagnetic radiation source which is pulsed and applied or focused to one or more small areas in order to achieve the necessary temperature rise or sufficiently stress the cells and tissue to stimulate heat shock protein production or activation and facilitate protein repair, while allowing the temperature to decay sufficiently quickly so as not to damage or destroy the treated tissue.

Abstract: A process for reducing hair damage upon treatment of hair by heat comprising the steps of providing a hair care composition comprising a heat-stable silicone material, applying said composition onto hair, providing a heat generating hair care appliance, and treating hair using said appliance; use and kit thereof.

Abstract: The invention relates to the use of a compound of formula (I), or salts thereof, as a preserving agent, in particular in a cosmetic, dermatological or pharmaceutical composition: in which R1 and R2 represent H, methyl, ethyl, phenyl or benzyl. The invention also relates to a method of preserving a cosmetic, dermatological or pharmaceutical composition, consisting in incorporating said compound of formula (I) therein; and also to the compositions thus obtained.

Abstract: A cosmetic treatment device includes a nitric oxide (NO) eluting polymer, a carrier, and a proton donor enclosed in a container that keeps the proton donor separate from the nitric oxide eluting polymer until the device is used. When the container is opened, proton donor contacts the polymer, causing the elution of nitric oxide from the polymer.